miR-184 represses β-catenin and behaves as a skin tumor suppressor

Lubov Turovsky; Ghazal Kheshaiboun; Gharam Yassen; Sara Nagosa; Ilanit Boyango; Aya Amitai-Lange; Swarnabh Bhattacharya; Neta Ilan; Israel Vlodavsky; Daniel Aberdam; Ruby Shalom-Feuerstein; Emily Avitan-Hersh

doi:10.1038/s41419-024-06554-4

miR-184 represses β-catenin and behaves as a skin tumor suppressor

Lubov Turovsky, Ghazal Kheshaiboun, Gharam Yassen, Sara Nagosa, Ilanit Boyango, Aya Amitai-Lange, Swarnabh Bhattacharya, Neta Ilan, Israel Vlodavsky, Daniel Aberdam, Ruby Shalom-Feuerstein, Emily Avitan-Hersh

Technion - Israel Institute of Technology

Research output: Contribution to journal › Article › peer-review

Abstract

miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.

Original language	English
Article number	174
Pages (from-to)	174
Journal	Cell Death and Disease
Volume	15
Issue number	2
DOIs	https://doi.org/10.1038/s41419-024-06554-4
State	Published - 26 Feb 2024

Keywords

Animals
Carcinogenesis/genetics
Carcinoma, Squamous Cell/pathology
Cell Line, Tumor
Cell Movement/genetics
Cell Proliferation/genetics
Gene Expression Regulation, Neoplastic/genetics
Humans
Mice
MicroRNAs/genetics
Skin Neoplasms/genetics
beta Catenin/genetics

All Science Journal Classification (ASJC) codes

Cellular and Molecular Neuroscience
Cancer Research
Cell Biology
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41419-024-06554-4

Cite this

@article{1089e96569764a279117b8306af62494,

title = "miR-184 represses β-catenin and behaves as a skin tumor suppressor",

abstract = "miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.",

keywords = "Animals, Carcinogenesis/genetics, Carcinoma, Squamous Cell/pathology, Cell Line, Tumor, Cell Movement/genetics, Cell Proliferation/genetics, Gene Expression Regulation, Neoplastic/genetics, Humans, Mice, MicroRNAs/genetics, Skin Neoplasms/genetics, beta Catenin/genetics",

author = "Lubov Turovsky and Ghazal Kheshaiboun and Gharam Yassen and Sara Nagosa and Ilanit Boyango and Aya Amitai-Lange and Swarnabh Bhattacharya and Neta Ilan and Israel Vlodavsky and Daniel Aberdam and Ruby Shalom-Feuerstein and Emily Avitan-Hersh",

note = "{\textcopyright} 2024. The Author(s).",

year = "2024",

month = feb,

day = "26",

doi = "10.1038/s41419-024-06554-4",

language = "الإنجليزيّة",

volume = "15",

pages = "174",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - miR-184 represses β-catenin and behaves as a skin tumor suppressor

AU - Turovsky, Lubov

AU - Kheshaiboun, Ghazal

AU - Yassen, Gharam

AU - Nagosa, Sara

AU - Boyango, Ilanit

AU - Amitai-Lange, Aya

AU - Bhattacharya, Swarnabh

AU - Ilan, Neta

AU - Vlodavsky, Israel

AU - Aberdam, Daniel

AU - Shalom-Feuerstein, Ruby

AU - Avitan-Hersh, Emily

PY - 2024/2/26

Y1 - 2024/2/26

N2 - miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.

AB - miR-184-knockout mice display perturbed epidermal stem cell differentiation. However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR-184 controls epidermal stem cell dynamics and that miR-184 ablation enhances skin carcinogenesis in mice. In agreement, repression of miR-184 in human squamous cell carcinoma (SCC) enhances neoplastic hallmarks of human SCC cells in vitro and tumor development in vivo. Characterization of miR-184-regulatory network, suggests that miR-184 inhibits pro-oncogenic pathways, cell proliferation, and epithelial to mesenchymal transformation. Of note, depletion of miR-184 enhances the levels of β-catenin under homeostasis and following experimental skin carcinogenesis. Finally, the repression of β-catenin by miR-184, inhibits the neoplastic phenotype of SCC cells. Taken together, miR-184 behaves as an epidermal tumor suppressor, and may provide a potentially useful target for skin SCC therapy.

KW - Animals

KW - Carcinogenesis/genetics

KW - Carcinoma, Squamous Cell/pathology

KW - Cell Line, Tumor

KW - Cell Movement/genetics

KW - Cell Proliferation/genetics

KW - Gene Expression Regulation, Neoplastic/genetics

KW - Humans

KW - Mice

KW - MicroRNAs/genetics

KW - Skin Neoplasms/genetics

KW - beta Catenin/genetics

UR - http://www.scopus.com/inward/record.url?scp=85186191717&partnerID=8YFLogxK

U2 - 10.1038/s41419-024-06554-4

DO - 10.1038/s41419-024-06554-4

M3 - مقالة

C2 - 38409173

SN - 2041-4889

VL - 15

SP - 174

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 2

M1 - 174

ER -

miR-184 represses β-catenin and behaves as a skin tumor suppressor

Abstract

Keywords

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this